The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Abstract
Idiosyncratic drug-induced liver injury (DILI) is common in gastroenterology and hepatology practices, and it can have multiple presentations, ranging from asymptomatic elevations in liver biochemistries to hepatocellular or cholestatic jaundice, liver failure, or chronic hepatitis. Antimicrobials, herbal and dietary supplements, and anticancer therapeutics (e.g., tyrosine kinase inhibitors or immune-checkpoint inhibitors) are the most common classes of agents to cause DILI in the Western world. DILI is a diagnosis of exclusion, and thus, careful assessment for other etiologies of liver disease should be undertaken before establishing a diagnosis of DILI. Model for end-stage liver disease score and comorbidity burden are important determinants of mortality in patients presenting with suspected DILI. DILI carries a mortality rate up to 10% when hepatocellular jaundice is present. Patients with DILI who develop progressive jaundice with or without coagulopathy should be referred to a tertiary care center for specialized care, including consideration for potential liver transplantation. The role of systemic corticosteroids is controversial, but they may be administered when a liver injury event cannot be distinguished between autoimmune hepatitis or DILI or when a DILI event presents with prominent autoimmune hepatitis features.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is the most widely used and accepted DILI diagnostic tool.2, 3”
From A revised electronic version of RUCAM for the diagnosis of DILI (2022) · cites this paper as [2]
In the citing paper
“The lack of a reliable diagnostic biomarker and evidence-based treatment paradigm has resulted in limited guidance on how to manage this aspect of DILI.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [26]
In the citing paper
“The lack of reliable diagnostic biomarkers and an evidence-based treatment paradigm has resulted in limited guidance on how to manage this aspect of DILI.2,25–27”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [26]
In the citing paper
“Data on corticosteroid use in DILI is scarce with no randomized controlled studies to evaluate their efficacy and safety; however, there are reports of corticosteroids having beneficial effects in patients with moderate or severe DILI.[18,23]”
From Drug-induced liver injury: Diagnosis, management and the role of liver transplantation (2025) · cites this paper as [18]
In the citing paper
“Data on corticosteroid use in DILI is scarce with no randomized controlled studies to evaluate their efficacy and safety; however, there are reports of corticosteroids having beneficial effects in patients with moderate or severe DILI.[18,23]”
From Drug-induced liver injury: Diagnosis, management and the role of liver transplantation (2025) · cites this paper as [18]
In the citing paper
“Although there are some ambiguities regarding how to score certain sections as well as suboptimal reliability, RUCAM can provide systematic and framed guidance for the assessment of patients with suspected DILI and is the most widely used tool [26,27,51,59].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [27]
In the citing paper
“Although there are some ambiguities regarding how to score certain sections as well as suboptimal reliability, RUCAM can provide systematic and framed guidance for the assessment of patients with suspected DILI and is the most widely used tool [26,27,51,59].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [27]
In the citing paper
“There is insufficient evidence suggesting that currently reported drug-and host-related risk factors can increase all-cause susceptibility to iDILI [1,27].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [27]
In the citing paper
“The RUCAM score, combined with expert opinion, may be the best current practical causality assessment method for establishing a diagnosis of HDS-DILI or HILI [27,59].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [27]
In the citing paper
“Therefore, the RUCAM score may show reduced reliability in the causality assessment of suspected HDS-DILI or HILI [27].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [27]
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 5×
“Summary and strength of recommendations statements that are not amenable to the GRADE process, either because of the structure of the statement or because of the available evidence.”
MethodInfluentialChalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,859
Self-citationBrahmer, J. R., Lacchetti, C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., Ernstoff, M. S., Gardner, J. M., Ginex, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6385 · Cited by 3,713
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Clèries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,473
Acetaminophen‐induced acute liver failure
Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., REISCH, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O., et al. (2005) · Hepatology · doi:10.1002/hep.20948 · Cited by 1,934
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A. S., Pisu, M., Melton, M. E., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,465
EASL Clinical Practice Guidelines: Wilson’s disease
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.007 · Cited by 1,239
Research works printed but not linked: 1
- Agarwal, 2010, Important elements for the diagnosis of drug-induced liver injury, Clin Gastroenterol Hepatol, 8, 463, 10.1016/j.cgh.2010.02.008 · DOI
Cited by
Sorted by citations
Items 301–400 of 430
Oliveira, L. D. A., FILHO, C. G. A. P. D. L., Rabelo, F. C. S., Taumaturgo, L. D. A., PEIXOTO, V. M. T., & Bachur, T. P. R. (2021) · Amplla Editora eBooks · doi:10.51859/amplla.tam726.2121-10
ACIDENTES POR TITYUS SERRULATUS: QUADRO CLÍNICO E TERAPÊUTICA
de Sousa, L. A., Alves, B. L. Q., Chaves, L. P. R., Bessa, L. B., Ramos, N. R. C., & Bachur, T. P. R. (2021) · Amplla Editora eBooks · doi:10.51859/amplla.tam726.2121-13
Diagnostics and Outcome Predictorso Drug Induced Liver Injury: A Single Center Prospective Study
Alhaddad, O., ElSharkawy, A. S., Hendy, O. M., Elsabaawy, M., Mazaly, M. A., & Sabry, A. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.215204
Drug‐Induced Liver Injury: A Mexican View
Contreras-Omaña, R., Alcántar, R. M., & Reyes, E. C. (2022) · Clinical Liver Disease · doi:10.1002/cld.1206
Predicting hepatotoxicity associated with low-dose methotrexate using machine learningPreprint
Hu, Q., Wang, H., & Xu, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1753066/v1
Cholestatic drug induced liver injury in active pulmonary tuberculosis patient: a case report
Theodora, A., & Suryana, K. (2022) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20222103
Predicting hepatotoxicity associated with low-dose methotrexate using machine learningPreprint
Hu, Q., Wang, H., & Xu, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1753066/v2
QSAR modeling for predicting drug-induced liver injury
Liao, T.-J., Zhao, J., & Chen, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15339-6.00009-6
Kathim, A. S., & AL-Hillo, M. F. (2023) · Bionatura · doi:10.21931/rb/css/s2023.08.01.3
Zheng, H., Zhou, K., Zheng, Z., Xiao, M., Wen, F., Wu, F., & Wu, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3441315/v1
Twee patiënten met acute toxische hepatitis na recente inname van thee
Deyaert, P., Colpaert, E. E., Pieters, A., & Vonck, A. (2023) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.79.23.074
Always Ask About Medicines and Supplements When Faced with Elevated Liver Enzymes
Peterson, A. R., & Boyapati, R. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-4440-8_76
Clinical and laboratory diagnostics of drug-induced liver injury by antibiotics
Bereznyakova, M., Залюбовська, О. І., Bereznyakov, I. G., & Lytvynenko, M. (2023) · Medicine Today and Tomorrow · doi:10.35339/msz.2023.92.4.bzb
DANO HEPÁTICO INDUZIDO POR TUBERCULOSTÁTICOS: PREVENÇÃO, DIAGNÓSTICO PRECOCE E MANEJO
Dutra, L. B., Lima, L. M. P., & Weber, G. A. (2023) · doi:10.56161/sci.ed.202312288c11
Drug-induced liver injury in tropical settings
Sonderup, M. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-87031-3.00033-0
Jüngst, C., & Kullak-Ublick, G. A. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21005-1.00051-2
Corredor-Rengifo, D., Sanchez-Romero, M., Ocampo-Posada, M., & Gómez-Ramírez, D. M. (2024) · Hepatología · doi:10.59093/27112330.102
Lesión hepática inducida por medicamentos secundaria al consumo de esteroides androgénicos
León, J. S. T., & Badillo, L. Y. E. (2024) · Gaceta Médica Boliviana · doi:10.47993/gmb.v47i1.800
Adetiloye, A. O., & Badero, O. J. (2024) · International Journal of Gastroenterology · doi:10.11648/j.ijg.20240801.16
Pistolesi, C., Spaggiari, R., Finello, V., Fortunato, V., Polastri, M., Gaban, A., Palagini, L., Grassi, L. G., Raparelli, V., Passaro, A., et al. (2024) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2024.100232
Zhang, X., Yang, F., Zhao, X., Wu, Q., He, L., Li, Z., Zhou, Z., Ren, T., Zhang, X., & Yuan, L. (2024) · Angewandte Chemie · doi:10.1002/ange.202410666
Tan, Z.-Y., Zhou, G., Feng, Y., Xiang, N., Li, S., Xie, R.-F., & Zhou, X. (2024) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2024.2391472
Wang, L., Chen, X., Wang, S., Wei, J., & Wang, J. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2418320
Hepatitis de tipo autoinmune inducida por nitrofurantoina: Un reporte de caso
Gonzalez, M. F. G., Mijangos, P. M., & Alvarez-Meza, J. A. (2024) · Revista de la Facultad de Medicina · doi:10.37345/23045329.v2i2.121
Pan, C., Zhou, X., Wang, Y., Wu, Y. Z., Han, Q., & Cui, X. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2449986
Acetazolamide-Induced Liver Injury: A Case Report and Literature Review
Mohiuddin, A., Hussain, F., Al-Ramadan, A., & Lilley, K. (2025) · Cureus · doi:10.7759/cureus.80536
Clinical Considerations of Drug-Induced Hepatotoxicity
Hundt, M. A., Mohamed, M. G. M., & Dara, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00275-8
Research Progress on the Etiology of Cholestatic Liver Disease in School-Age Children
李, 小. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541133
Hanifa, A. M., Saifudeen, S. F., Murugesan, H., Sivadasan, S., & Murugesan, K. (2025) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2025.v11i04.017
Lin, L., Guo, L., Long, M., Niu, M., Guo, Y., Zhu, S., Bai, Z., Zhao, X., Zhai, H., & Xiao, X. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119986
Abdelhady, A. M., Ayman, M., & Abdelmageed, M. E. (2025) · Journal of Applied Veterinary Sciences/Journal of Applied Veterinary Sciences · doi:10.21608/javs.2025.375952.1588
Duggal, S., Kattamuri, L. P. V., & Sairam, S. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.108051
Idiosyncratic Drug-Induced Liver Injury in a Patient With Metastatic Melanoma
Ottley, A., Thornton, A., Gil, R. A., & Sardinas, G. (2025) · Cureus · doi:10.7759/cureus.89482
Yang, Y., Cai, J., Tang, W., Zhang, B., Hu, Y., Han, W., Yang, G., Qu, M., Xu, L., Guo, X., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5388601
Myths and facts about the role of diet in metabolic dysfunction-associated steatotic liver disease
Fernandes, S. A. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i8.107909
A Rare Case of Drug-Induced Liver Injury Due to Metformin and Literature Review
刘, 清. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1592514
Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET® in Japan
Kinoshita, Y., Ando, T., Kajiyama, K., Maruyama, H., Kohama, M., Tanaka, A., Matsunaga, Y., Ishiguro, C., Nonaka, T., Horiuchi, N., et al. (2025) · Hypertension Research · doi:10.1038/s41440-025-02390-x
Impact of Alcohol Use on Nonalcohol-Related Liver Diseases
Blaney, H. L., Waterman, A., & Kaplan, A. J. (2025) · Clinics in Liver Disease · doi:10.1016/j.cld.2025.09.002
Acute liver failure caused by alkaloids from traditional Chinese medicine: A case report
Zhu, X.-Y., Zhao, Y.-T., Su, C.-S., Yuan, X., Zhang, S., & Nashan, B. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i10.109575
Autoimmune Hepatitis: Histopathological Spectrum and Diagnostic Implications
Komuta, M., & Harada, K. (2025) · Kanzo · doi:10.2957/kanzo.66.473
Advances in the Pathogenesis of Drug-Induced Liver Injury
焦, 军. (2022) · Pharmacy Information · doi:10.12677/pi.2022.113022
Derymedvid, L. V., & Petroshchuk, S. R. (2025) · Likarska sprava · doi:10.31640/ls-2025-4-18
Autoimmune Hepatitis: Histopathological Diversity and Its Clinical Implications
Komuta, M., & Harada, K. (2025) · Hepatology Research · doi:10.1111/hepr.70103
Wang, H.-Y., Huang, Y., Chen, X.-Z., Zhang, Z., & Gui, C. (2022) · Figshare · doi:10.6084/m9.figshare.21523670
Liu, Y., Li, H., Huang, L., Wan, C., Wang, H., Jiao, X., Zeng, L., Jia, Z., Cheng, G., Zhang, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24217343
Gaihre, M., Jha, S., Pathak, R., Ghimire, S., Baranawal, P., Poudel, A., & Bhatta, R. (2025) · Medical Reports · doi:10.1016/j.hmedic.2025.100374
DRUG-INDUCED LIVER TOXICITY: MECHANISMS AND THERAPEUTIC TARGETS
Manna, S., Sarkar, S., Saha, N. C., & Banerjee, P. (2025) · doi:10.65525/svup.9788198800473.2025.199-208
Complementary and Alternative Medicine-Induced Combined Hepatorenal Toxicity: A Case Report
Zacharia, G. S., Ravte, V., Jyala, A., & Shehi, E. (2025) · Cureus · doi:10.7759/cureus.100197
Alzubaidi, H. Y. S., Wafi, A. A. A., Alotaibi, T. M. M., Alenazi, S. S., Alshammari, F. S., Alasmari, N. H. A., Alotaibi, M. S., Name, A. I. H. A., Alotaibi, Z. S. M., Almanassif, Y. J. A., et al. (2024) · Saudi Journal of Medicine and Public Health · doi:10.64483/202412397
Fayzullayeva, N., Kayumov, A., Aripova, T., Анварович, Р. А., Muxtorov, S., Баратов, К. Р. У., Farxodovna, T. S., Askarov, T., Nabiyeva, U., Eshbekov, M., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8601812/v1
Farah, H. S., Abdulsahib, W. K., Jasim, I. K., Menon, S. V., Patro, P. S., Sabarivani, A., Mukherjee, G., Sinha, A., & Rizaev, J. (2026) · Natural Product Research · doi:10.1080/14786419.2026.2613344
Takahashi, K. (2026) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2026.102785
Bogatyreva, M., Kharsanova, A., Kalugina, O., & Azhimatova, M. R. (2026) · Bulletin of Science and Practice · doi:10.33619/2414-2948/123/45
Lei, J., Wang, Y., Jin, Z., Qin, G., Liu, T., Zhang, N., & Lv, M. (2026) · BMC Cancer · doi:10.1186/s12885-026-15801-0
Rani, F., Awana, R., Patwa, A. K., Sindhu, S., Verma, A., & Singh, S. (2026) · Cureus · doi:10.7759/cureus.105041
Uehara, Y., Imai, N., Takahashi, Y., Endo, Y., Kimura, K., Hirano, Y., Horigome, Y., & Kawashima, H. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062317
Spatiotemporal trends in the global burden of drug-induced chronic liver diseases in thirty years
Qian, K., Yu, L., Zhu, J., Liu, J., & Yu, Z. (2026) · Precision medication. · doi:10.1016/j.prmedi.2026.100075
Neupane, A., Chhetri, A., Gonzalez, M., Ghimire, A., & Gohar, A. (2026) · Cureus · doi:10.7759/cureus.106524
Kozar, M., Gonzalez, Y., & Marzio, D. H. (2026) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s572371
Valentin, L. (2022) · theses.fr (ABES) · doi:10.70675/7d4d9dbaz2221z473ez8d83z615f5c28bdb7
Albusta, N., Ali, A., YUSUF, A., & Alrahma, H. N. S. (2026) · Cureus · doi:10.7759/cureus.106719
Alanzi, T. S. K., Alghuraydh, H. I. A., Alsalmi, A. T. Z., Aljohani, K. S. A., AlJuhani, A. I. H., Alsaif Salem Abdulaziz, S., Alshehri, A. M. A., Alanazi, O. S. O., & Alraweli, A. M. O. (2024) · International Journal of Computational and Experimental Science and Engineering · doi:10.22399/ijcesen.5138
Lyu, M., Li, J., Hu, R., Mm, M., Huang, Q., Fan, K., Wang, Y., Yang, J., Cai, B., Wu, Q., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202504908r
Alabrahim, O. A. A., & Allam, N. K. (2026) · Inflammation and Regeneration · doi:10.1186/s41232-026-00413-9
Teskey, G., Shadarevian, M. H. D., Chow, W., Gauerke, S., & Wong, S. (2026) · Cureus · doi:10.7759/cureus.107492
Hull, M. L., & Blair, C. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44037-3.00202-5
Li, Q., Lin, Y., Zeng, X., Zhou, L., Wang, F., Ye, Q., Gao, Y., Guo, L. L., Zhu, J., Li, J., et al. (2026) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848261440777
Hepatitis autoinmune inducida por metildopa en el embarazo: reporte de caso
Arias-Choles, A. M., Morales-Morales, M. V., & Luján-Ramos, M. A. (2026) · Hepatología · doi:10.59093/27112330.173
Hu, S., Kong, L., Chen, M., Teng, C., Zhao, Y., Yuan, X., Cai, S., Zhu, X., & Xu, P. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026094
Oyinloye, E. O., Murtala, A. A., Oladoja, F. A., Aderinola, A. A., Tijani, R. O., & Soyinka, O. O. (2025) · Nigerian Journal of Pharmaceutical Research · doi:10.4314/njpr.v21i2.9
Chelidonium majus-Induced Hepatitis: A Case Report of Herb-Induced Liver Injury
Adamidis, N., Adamidi, S., Georgakopoulou, V., Miliou, S., Karampela, A., Stratopoulos, E., Margariti, T., Sakizlis, G., & Adamidis, S. (2026) · Cureus · doi:10.7759/cureus.109572
Омелянович, С. В., Гладких, Ф. В., Лядова, Т. І., & Матвєєнко, М. С. (2026) · Health & Education · doi:10.32782/health-2026.1.14
Zhu, J., Li, W., Zhu, Y., Shao, N., Zhu, J., Hu, Y., & Dong, J. (2026) · PubMed · doi:10.11817/j.issn.1672-7347.2026.250442
Qiu, L., Xue, M. L., Feng, H., Meng, F., Zheng, Y., Cheng, G., Zhang, Y., Yin, Z., Wu, J., Zhu, J. F., et al. (2026) · European Radiology · doi:10.1007/s00330-026-12644-y
Zhang, Y., Wang, L., Mao, J., Wu, Y., Foo, W., Wang, Z., Wu, J., Guo, Y., You, J., & Luo, L. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115091
Ajith, A., Krishnamoorthy, R., Ashwin, A., Kumar, S., & Rathan, N. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.53s.139
Lambarth, A. T., & Threapleton, C. J. (2026) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2026.06.001
Pakal, Y. K., Dharap, N. P., Gade, S. N., & Ingole, J. R. (2026) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20262201
Ways to increase the efficiency of nitrofurantoin synthesis
Стойка, А., & Stoyka, A. (2026) · DSpace BSMU
Fenbendazole-Associated Drug-Induced Liver Injury with Concomitant Use of Tauroursodeoxycholic Acid
Satinsky, A., Mayer, N., Swanson, C., & Sasso, B. (2026) · ACG Case Reports Journal · doi:10.14309/crj.0000000000002222
Vanished Without a Trace: A Middle‐Aged Man With Vanishing Bile Duct Syndrome—A Case Report
Mendoza, E., Jurado, A., Gulla, V., Franco, G. R., Padilla, O., Elhanafi, S. E., Chozet, L. E., & Bright, T. M. (2026) · Case Reports in Gastrointestinal Medicine · doi:10.1155/crgm/4371217
Liu, Y., Liu, Z., Luo, C., Chen, W., Xia, Z., Zhou, H., Huang, J., You, M., & Yang, G. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168328
Михневич, Е. А., Лемешевская, С. С., & Рубан, А. А. (2026) · Рецепт · doi:10.34883/pi.2026.29.3.010
Liang, A., Castillo, Y. C., Madera, M. D. F., Sairaj, R. T., Medina, J., Díaz, T. A. M., Chintamaneni, S., Monar, G. F., Cruz, C. S., Advani, R., et al. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.101045
DAĞ, Ş. R. O., Dağ, N., Akbulut, S., Harputluoglu, M. M., & Yılmaz, S. (2026) · Medicina · doi:10.3390/medicina62071290
Re-exploration of the pharmacotherapeutic strategy for drug-induced liver injury: a narrative review
Liu, Y., Guo, Y. Z., Xu, H., Han, Y., Feng, H., Yutao, F., & Pan, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1880114
Unregulated gains: a case of RAD-140–induced liver injury
Dao, D., King, B., Dao, H., & Bahirwani, R. (2026) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2026.2691619
Quek, Y.-L., Zeng, Y., Ge, X., Low, M., Ng, P. S. L., Tham, M. Y., & Soh, S. B. L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1872698
Rani, F., Biswas, S., & Verma, S. K. (2026) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2026.27.1.0384
Toxicological assessment of a bioactive adaptogenic drug for use in rats and pigs
Korkh, I. V., Koreneva, Y. M., Boikо, V. М., Gerilovych, I. O., Korkh, O. V., Владимировна, К. Л., Paliy, А., Boyko, N., Владимировна, К. Л., & Livoshchenko, Y. M. (2026) · Regulatory Mechanisms in Biosystems · doi:10.15421/0226103
Tran, N. T., Pham, T. M., Ngo, M. T. Q., Tran, A. V., Ninh, T. T. K., Nguyen, L. D., Hoang, D. V., & Phương, N. T. T. (2026) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986261467891
Liu, C., Zeng, C., He, F., & Kuang, W.-A. (2026) · RSC Advances · doi:10.1039/d6ra04366f
Rafeeq, F. K., & Althanoon, Z. A. (2026) · Tikrit Journal of Pharmaceutical Sciences · doi:10.25130/tjphs.2026.20.1.4.33.42
Seo, Y., & Woo, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167111
Qiu, D., Gao, Z., Zhang, L., Ma, T., Wei, X., Zhang, Z., Cao, W., Li, X., Wang, S., Deng, W., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1890794
Liver-on-a-chip: Applications for clinical modeling of liver disease using microscale systems
Brooks, N. M., Peczak, A., & Schwartz, R. E. (2026) · Hepatology · doi:10.1097/hep.0000000000001829
Feng, X., Wang, F., Xie, L., & Zhang, H. (2026) · Hepatitis Monthly · doi:10.5812/hepatmon-171058
Risk factors for antipsychotic- and antidepressant-associated liver function abnormalities
Zhu, J., Zhou, Q., & Xiu, Y. (2026) · Medicine · doi:10.1097/md.0000000000050232
Kassaw, A. T., Wondm, S. A., Mussie, D. A., Tarekegn, G. Y., Zerihun, T. E., Moges, T. A., Zewdu, W. S., Beriso, E. A., Tamene, F. B., Melese, T. B., et al. (2026) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2026-004745
Metadata
- Authors
- Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology
- Affiliations
- Indiana University Indianapolis (US)
- Northwestern University (US)
- Carolinas Medical Center (US)
- VA Palo Alto Health Care System (US)
- University of Pennsylvania (US)
- Corresponding author
- Chalasani, Naga P.
- Venue
- American Journal of Gastroenterology
- Published
- 2021-05
- Volume
- 116
- Issue
- 5
- Pages
- 878-898
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W4205136705
- Semantic Scholar
- 2c1e0585092198394e24121ea3fbf9704f76ae03
- Cited by
- 430
- References
- 165
- Citations by year
- 2026: 103 · 2025: 94 · 2024: 85 · 2023: 65 · 2022: 65 · 2021: 18
- FWCI
- 34.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- idiosyncratic drug-induced liver injury, drug-induced liver injury, diagnosis of exclusion, hepatocellular jaundice, cholestatic jaundice, liver failure, chronic hepatitis, antimicrobial agents, herbal and dietary supplements, tyrosine kinase inhibitors, immune checkpoint inhibitors, Model for End-Stage Liver Disease, comorbidity burden, mortality, liver transplantation, corticosteroids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
